Press releases
* (R) = Regulatory press releases
Nov 27, 2017
(R) Extraordinary general meeting in Cantargia
Oct 6, 2017
(R) Cantargia obtains patent approval in USA for the antibody CAN04 in development for treatment of cancer
Aug 31, 2017
(R) Cantargia obtains patent approval in Europe for the antibody CAN04 in development for treatment of cancer
Aug 23, 2017